Select Page

Home » Videos » PCOS Stimulation in non IVF Cycles | PCOS Stimulation Protocol

Stimulation in PCOS Patients in Non-IVF Cycles: A Detailed Guide

UPDATED ON 5TH AUG. 2024

Polycystic Ovary Syndrome (PCOS) is a complex condition, especially when it comes to stimulation in non-IVF cycles. In this blog, we will break down the process to make it simpler for clinical practice.

So, without wasting much time, let’s dive into the topic right away.

AUTHOR

Dr Jay Mehta

Scientific Director & IVF Specialist with 10+ years of experience

TREATMENT

IVF

GET IN TOUCH ON

Understanding the Mechanism of Action in PCOS

Before diving into stimulation techniques, it’s essential to understand the mechanism of action in PCOS. PCOS patients typically exhibit insulin resistance, leading to compensatory hyperinsulinemia. This condition significantly impacts the ovary, altering its pathway and resulting in an androgenic microenvironment.

Insulin resistance causes excessive insulin, which activates the serine pathway in the ovary, increasing androgen production. Alongside, there is an altered LH (luteinizing hormone) excess, further contributing to the androgenic environment. This combination results in the recruitment and simultaneous apoptosis of follicles, leading to chronic anovulation and infertility. Understanding this mechanism is crucial for effectively managing PCOS.

The Target in Non-IVF Stimulation

In non-IVF cycles, the goal is to stimulate the ovary to produce a specific number of follicles. For natural intercourse in PCOS patients, the target is one to two follicles. For intrauterine insemination (IUI), the aim is to recruit around three follicles. Achieving these targets without overstimulation is critical to avoid complications like Ovarian Hyperstimulation Syndrome (OHSS).

We Are Always There For You. Call Us 24/7 For Any Help

Preferred Drugs for Stimulation

The drug of choice for stimulating PCOS patients in non-IVF cycles is Letrozole (LET). It is preferred over Clomiphene Citrate due to its effectiveness and fewer side effects on the endometrium. The standard protocol involves:

  • For thin PCOS patients aiming for natural intercourse: Letrozole 2.5 mg for five days.
  • For thin PCOS patients undergoing IUI: Letrozole 2.5 mg twice a day for five days, with an optional addition of HMG.
  • For obese PCOS patients: Letrozole 2.5 mg twice a day for five days, with an optional addition of HMG.

The Role of HMG in Stimulation Protocols

Human Menopausal Gonadotropin (HMG) is added to enhance follicular recruitment. The standard dose is 150 international units. HMG helps in achieving better recruitment, especially in PCOS patients who might have altered LH levels. It’s important to understand that HMG aids in the initial recruitment phase, ensuring that the targeted number of follicles is achieved.

We Are Always There For You. Call Us 24/7 For Any Help

Addressing Protocol Failures

If a patient has undergone three to four cycles without success, the extended Letrozole protocol can be considered. This involves administering Letrozole 2.5 mg twice a day for 8 to 10 days. Adding HMG or low-dose HCG may also be beneficial in these cases. This extended protocol helps in cases where standard dosages fail to stimulate sufficient follicular growth.

Adjuvant Therapies in PCOS Stimulation

Metformin benefits both thin and obese PCOS patients as it improves insulin sensitivity. Low-dose steroids like Prednisolone 5 mg can also be considered, especially in obese patients.

However, there is no established role for myo-inositol or d-chiro-inositol in improving insulin sensitivity in these protocols. These adjuvant therapies help in managing the underlying metabolic disturbances in PCOS.

Triggering Ovulation and Luteal Phase Support

The trigger for ovulation in these cycles is 10,000 IU of HCG. For luteal phase support, progesterone gel (8%) is used, either once or twice a day, depending on the patient’s needs. This support is crucial because, in PCOS, there is often an abnormal LH environment which can compromise the luteal phase if not supported adequately.

Managing Thin Endometrium in PCOS Patients

PCOS patients often have a thin endometrium due to elevated androgen levels. This can be managed by using HMG, which helps in creating an estrogenic microenvironment, promoting better endometrial growth. Additionally, adding low-dose HCG can further enhance the endometrial receptivity, improving the chances of implantation.

The Role of Lap Ovarian Drilling

Lap ovarian drilling is rarely recommended, usually for patients resistant to stimulation after several cycles. It is considered when there is a thick ovarian cortex due to high androgen levels. This surgical intervention can help reduce androgen levels locally, improving the ovarian response to stimulation in subsequent cycles.

When to Consider Conversion to IVF?

Conversion to IVF should be considered if there is a hyper-response or no response after several cycles of non-IVF stimulation. In such cases, higher doses of HMG or pure HMG cycles might be required, and these should ideally be managed in an IVF setup to prevent complications like OHSS. Proper counseling and planning are essential before initiating stimulation to ensure a smooth transition if needed.

Common Challenges and Solutions in PCOS Stimulation

Unexpected challenges such as poor follicular response or hyper-response can be managed by adjusting the protocol.

For example, using extended Letrozole protocols or pure HMG cycles can help. Monitoring and adjusting the dose based on patient response is crucial. Additionally, ensuring the patient’s metabolic parameters are well-managed with adjuvant therapies can significantly impact the stimulation outcomes.

Importance of Monitoring and Personalized Treatment

Regular monitoring through ultrasound and hormonal assays is essential in managing PCOS patients undergoing stimulation. Personalized treatment plans based on the patient’s response and metabolic profile can enhance success rates. It’s also important to educate the patient about lifestyle modifications that can support the treatment.

Wrapping Up

Stimulation in PCOS patients for non-IVF cycles involves a clear understanding of the underlying mechanism and a careful selection of drugs and protocols. Letrozole is the preferred drug, with HMG added as needed. Monitoring and managing each patient’s response ensures successful stimulation and reduces complications.

We hope this guide has offered you a lot of information about PCOS stimulation. If you still have some doubts, do not hesitate to reach out. We are here to help.

AUTHOR

Dr Jay Mehta

Scientific Director & IVF Specialist with 10+ years of experience

TREATMENT

IVF

CALL US 24/7 FOR ANY HELP

GET IN TOUCH ON

Share Article on

[DISPLAY_ULTIMATE_SOCIAL_ICONS]

Recommended Reading

Hidden Cost of IVF Treatment

Hidden Cost of IVF Treatment

A single IVF cycle in India can cost anywhere from ₹1,50,000 to ₹2,25,000. Some clinics offer lower prices but may exclude medicines, freezing, and hatching from the package

DuoStim/ Dual Ovarian Stimulation in IVF

DuoStim/ Dual Ovarian Stimulation in IVF

DuoStim is an option for women with low AMH, providing stimulation twice in one cycle from days 2-4 of their period to enhancing the chance for egg retrieval